Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis

The Journal of Investigative Dermatology
Jeng-Wei TjiuShiou-Hwa Jee

Abstract

Cyclooxygenase-2 (COX-2) is critical for tumor formation, angiogenesis, metastasis, and prognosis. In this study, the role of COX-2 in antiapoptosis, tumorigenesis, and angiogenesis of human basal cell carcinoma (BCC) cells was investigated. Transfection of COX-2 constitutive expression vector into a BCC cell line yielded several overexpressing clones. All transfectants demonstrated remarkable resistance to ultraviolet B-induced apoptosis (confirmed by flow cytometry analysis, morphological change, and DNA fragmentation). Immunoblot analysis revealed marked increases in apoptosis-regulated genes Mcl-1 and Bcl-2. A 10-fold concentrated conditioned medium from COX-2-overexpressing BCC cells exhibited higher angiogenic activity in Matrigel plug and human umbilical vein endothelial cell tube formation assay. Cells exhibited increased levels of vascular endothelial growth factor-A (VEGF-A) mRNA and protein, and secreted VEGF-A and basic fibroblast growth factor (bFGF). COX-2-specific small interfering RNA markedly reduced the secreted species. After 7 weeks of inoculation, the tumor volume of COX-2-overexpressing cells in severe combined immunodeficient mice was significantly greater than that of vector control cells. Immunohistoche...Continue Reading

References

May 1, 1994·Journal of the American Academy of Dermatology·D L Miller, M A Weinstock
Nov 12, 1998·Journal of the National Cancer Institute·M M Taketo
Mar 30, 2001·The Journal of Biological Chemistry·C H LiuT Hla
Jun 13, 2001·Journal of Cutaneous Pathology·M KagouraM Morohashi
Oct 31, 2001·Journal of Photochemistry and Photobiology. B, Biology·F R de GruijlL H Mullenders
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ang YuanPan-Chyr Yang
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ugochukwu C NzeakoGregory J Gores
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Douglas J E ElderChristos Paraskeva
Sep 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Karin Muller-DeckerGerhard Furstenberger
Sep 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Li MaJohn L Wallace
Sep 23, 2003·Mechanisms of Ageing and Development·Jin Young SeoJin Ho Chung
Jun 4, 2004·The Journal of Investigative Dermatology·Traci A WilgusTatiana M Oberyszyn
Jan 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J DannenbergRaymond N DuBois

❮ Previous
Next ❯

Citations

May 7, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brett G ZaniElazer R Edelman
Feb 3, 2007·American Journal of Veterinary Research·Carey L McInnisJames R Turk
Jul 29, 2010·Expert Opinion on Investigational Drugs·Po-Lin SoErvin H Epstein
Jun 5, 2012·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S Sinan ÖzalpAyşe Tansu Koparal
Jan 16, 2008·Photochemistry and Photobiology·Joyce E Rundhaug, Susan M Fischer
Jan 9, 2008·Photochemistry and Photobiology·Mark S EllerBarbara A Gilchrest
Jul 17, 2008·Photochemistry and Photobiology·Nannan ChenConnie B Lin
Mar 7, 2012·Free Radical Biology & Medicine·Joydeb Kumar Kundu, Young-Joon Surh
Aug 12, 2009·Current Opinion in Pharmacology·Bharat B Aggarwal, Prashasnika Gehlot
Sep 1, 2016·Disease Markers·Mihai LupuDaniela Elena Costea
Jun 12, 2014·Revista da Associação Médica Brasileira·Juliano Schmitt, Hélio Miot
Jun 21, 2012·Anais Brasileiros De Dermatologia·Juliano Vilaverde Schmitt, Hélio Amante Miot
Feb 8, 2011·Cancers·Joyce E Rundhaug, Susan M Fischer
Apr 20, 2007·Molecular Carcinogenesis·Joyce E RundhaugSusan M Fischer
Nov 13, 2012·Acta neurochirurgica·Sabrina FriedrichMakoto Nakamura
Jul 25, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Yang Chen, Jilong Liu
Oct 3, 2019·The British Journal of Dermatology·C W Rundle, R P Dellavalle
Oct 2, 2012·Biomedical Optics Express·Nai-Chia ChengSheng-Lung Huang
Dec 4, 2014·Molecular and Clinical Oncology·Lucia HiľovskáPeter Fedoročko
Jun 28, 2011·Journal of Agricultural and Food Chemistry·Nan-Lin WuChi-Feng Hung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.